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ABSTRACT 
 
Aims: To evaluate total antioxidant capacity, anticancer activity and antibacterial effects Withania 
somnifera aqueous-root extracts. 
Study Design: In vitro study. 
Place of Study: School of Biomedical Sciences, Ulster University, UK.  
Methodology: Total antioxidant capacity (TAC) of whole powder and freeze dried W. somnifera 
aqueous-root extracts was determined using FRAP, DPPH, Folin and ABTS assays. Anticancer 
activity was accessed using MDA-MB-231 breast cells and Sulforhodamine B staining for cell 
viability. Antibacterial activity was by disk diffusion assay with penicillin, amoxicillin and 
streptomycin as positive controls. 
Results: The TAC for W. somnifera extract was 86, 47, 195,or 443 gallic acid equivalents per 100g 
dry basis (mgGAE/ 100 g) using FRAP, DPPH, Folin or ABTS assays, respectively. Corresponding 
TAC values for freeze dried W. somnifera aqueous-root extract were, 418, 553, 1898 or, 1770 
(mgGAE/100 g). W. somnifera aqueous-root extract inhibited MDA-MB-231 cell proliferation in a 
dose-dependent manner with IC50 = 0.19 mg/ml (21 µM GAE). Nil antibacterial effects were 
detected for freeze dried W. somnifera extract (0-1 mg/ml) across six species of bacteria tested. 
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Conclusion: Withania somnifera root water extract showed significant antioxidant and anticancer 
activity for MDA-MB-231 breast cancer cells but no antibacterial activity under the conditions of this 
study. 
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1. INTRODUCTION 
  
Withania somnifera (Ashwaganda, Indian 
ginseng or Winter cherry) is a member of the 
Solanaceae family found naturally in Africa, Asia 
(temperate/ tropical) and Europe [1]. Health uses 
of W. somnifera can be traced from 5000BCE to 
Hindu Ayurveda medical practices. Recent 
chemical analysis showed diverse components, 
including alkaloids, steroidal lactones, and 
flavonoids; [2-5]. The in-vitro antioxidant activity 
of W. somnifera roots extracts were determined 
as part of routine investigations [6-9] with both 
extracts and isolated components reported to 
inhibit breast cancer cells [10-14]. The 
antimicrobial activity of W. somnifera extracts 
received increasing interest over the recent past 
as shown by representative studies [7,15-19].  
 
Currently, a few studies examined the anticancer 
effect of root extracts W. somnifera [20-22] and 
comparatively less research dealt with aqueous 
extracts [23]. To our knowledge, no publication 
has compared the antioxidant, anticancer and 
antimicrobial activity for W. somnifera within a 
single study. To fill the perceived research gap, 
the aims of this study were to evaluate                 
W. somnifera aqueous root extracts, for 
antioxidant, anticancer and antibacterial effects 
in-vitro. 
 
2. MATERIALS AND METHODS  
 
2.1 Materials and Extract Preparation 
 
USDA approved organic W. somnifera root 
power was purchased from a licensed herbal 
dealer. Chemicals and reagents including 2, 2-
diphenyl-1-picrylhydrazyl, Folin Denis reagent 
and 2, 2’-azino-bis (3-ethylbenzothiazoline-6-
sulphonic acid) were obtained from Sigma- 
Aldrich.  Nutrient broth and nutrient agar were 
both purchased from Oxoid. Aqueous root extract 
was prepared by adding 1 g of whole                     
W. somnifera root powder to 19 ml of water, and 
stirring for 1 hour, centrifuging (13000 rpm for 20 
minutes), freezing at -80ºC overnight and freeze 
drying. 
2.2 In vitro Assay for Total Antioxidant 
Capacity 
 
Assays for total antioxidant capacity (TAC) were 
adapted to microplate analysis as described 
previously [24]. The ferric Reducing Ability of 
Plasma (FRAP) assay was adapted from [24] 
and samples were read at 593nm in a microplate 
reader. The Folin assay for total phenol was 
performed as described in [25] and read at 
760nm using a microplate reader. The DPPH (2, 
2-diphenyl-1-picrylhydrazyl) assay was adapted 
from [26] and samples were read at 515nm using 
a microplate reader. The ABTS (2, 2’-azino-bis 
(3-ethylbenzothiazoline-6-sulphonic acid) assay 
was adapted from [27] and the final solution 
mixtures measured at 734nm using a microplate 
reader.  All assays were calibrated with 0-3 mM 
gallic acid as reference antioxidant.   
 
2.3 Anticancer Assay 
  
MDA-MB-231 breast cancer cells were grown in 
DMEM with 10% FBS, 1% PenStrep and 1% 
non-essential amino acids. Trypsinized cells 
were plated (10,000 per well) and allowed attach 
overnight. Freeze dried W. somnifera (5 mg/ml) 
in complete culture medium was filter sterilized 
and 1:5 serial dilutions were added to cells for 72 
hrs. Cells viability was determined using 
sulforhodamine B staining [28]. 
 
2.4 Antibacterial Methods 
 
Three Gram positive (B. cereus, S. aureus,            
S. epidermis), and Gram negative (Salmonella 
typhi, E. coli and Pseudomonas aeruginosa) with 
verified, identity and phenotypes were used. 
Antimicrobial activity was evaluated by disk 
diffusion assay as described by [17]. Control 
antibiotic disks contained either streptomycin, 
amoxicillin or, penicillin; two blank discs were 
placed, at equal distances on the agar plate.  
Freeze dried plant extract (1 mg/ml) was added 
to discs one drop at until the disk was saturated.  
 
2.5 Statistical Analysis  
 
Statistical analysis was carried out using 
Microsoft excel and the IBM SPSS v22 statistic 
package for Microsoft Windows for ANOVA 
analysis. Significance level was at (
across all tests. 
 
3. RESULTS AND DISCUSSION
 
3.1 Total antioxidant Capacity Assa
  
The total antioxidant capacity (TAC) for 
W. somnifera root aqueous-extract and the 
freeze dried extract (Table 1) reflected the 
method of analysis (ABTS > Folin > FRAP 
DPPH) and values were significantly different for 
all assays (p=0.05). The total phenols values (95 
& 1898 mg GAE/100 g) for whole water extract 
and freeze dried extract, compare with 60 
mg GAE/100 g reported previously [6,
total phenols value for the W. somnifera 
extracted with 80% hot methanol was 600
GAE/100 g [9]. The FRAP values (86 
GAE/100 g) compares well with 167
GAE/100 g (converted from 500-600 mg trolox 
equivalent/ 100 g) reported for W. somnifera
methanolic extract [9]. ABTS analysis for 
somnifera root water-extract produced
218 mgGAE/100 g (from 938 mg trolox 
equivalents/ 100 g) [7] compared with  443 and 
 
Table 1. Antioxidant activity for whole powder (WP) and freeze dried 
aqueous extracts across four 
 
Assay* LDR (µM) 
FRAP 0-25 
DPPH 0-25 
Folin Denis  0-75 
ABTS 0-20 
Results from 3-replicates, n >
*LDR =Range of concentrations or which calibration graph is straight, 
R
2
 = Correlation coefficient. ‡Total antioxidant capacity (TAC) expressed as gallic acid equivalents (GAE) per 
100g dry weight. Within each column all TAC are significantly different at (P=0.05)
 
 
Fig. 1. Effect of different doses of aqueous extracts from 
0.02, 0.1, 0.5, 2.5 mg/ml) on MDA
Bars shows means (+/- SEM) for 3 independent experiments (n= 18) per treatment,
Different letters on each column show significant differences (P=0.05)
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P=0.05) 
 
y 
           
> 
-1107 
7]. The 
root 
 mg 
- 418 mg 
-200 mg 
 
W. 
 a TAC of 
1770 mg GAE/100 g from this study. In 
summary, the TAC for W. somnifera 
by the extraction conditions (solvent used, 
temperature and time of extractio
maturity and botanical part of the plant selected. 
W. somnifera leaves had 3-4 times higher 
phenols and TAC compared with roots for the 
fully mature plant [9] whilst other investigators 
found no systematic difference [8,
present paper provides a unique comparison of 
TAC for the W. somnifera root extracts using four 
different assays, which is important because 
different antioxidant methods employ different 
mechanisms [29]. 
 
3.2 Anticancer Activity towards 
231 Breast Cancer Cells 
 
Breast cancer is the most common cancer 
among women globally with 1.67 million new 
cases diagnosed in 2012 and accounting for 25% 
of all cancers [30]. W. somnifera
and isolated components were reported to inhibit 
breast cancer cells [10-14] but few studies 
examined the anticancer effect of root extracts 
[20-22] and studies using aqueous
limited [23]. In the present study (Fig. 1), freeze
Withania somnifera
in-vitro antioxidant assays 
 (M cm-1) R
 2
 TAC ‡(WP) TAC
195014  0.997 86±11 418 ±12 
92886  0.989 47±8
 
 553.1±31
25836  0.981 195±11 1898±57
50642  0.988 443±28  1770±57
48 data points, WP = whole powder, FD = freeze dried extract
 (M cm-1) = molar absorptivity, 
 
W. somnifera root powder (0.004, 
-MB-231 cell viability with 72hr treatment
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is influenced 
n), plant 
17]. The 
MDA-MB-
 leaf extracts 
-extracts are 
 
‡(FD) 
 
 
 
 
 
 
 
 
 
dried W. somnifera aqueous root extracts were 
found to be cytotoxic to MDA MB 231 breast 
cancer cells with 50% inhibitory concentration 
(IC50) at 0.19 mg/ml for 72 hr. treatment. Cell 
viability was just over 10% at the highest 
concentration used. By comparison, a previous 
report found the IC50 was 0.48 mg/ml and 0.032 
mg/ml for aqueous and ethanoic extracts from 
the roots of W. somnifera tested with MDA
231 cell line though there were detailed 
differences in experimental method [23]. T
general agreement that both leaf and root 
extracts from W. somnifera possess anticancer 
activity [31]. Interestingly a previous study 
showed that leaf and root extract had similar 
anticancer activity though more exhaustive 
studies are needed [14].  
 
Weather the anticancer and TAC activity of 
W. somnifera are related is uncertain  To 
address this issue, we estimated the IC50 value 
for freeze dried W. somenifera extract
total phenols content of samples ( IC50 (mol/l) = 
0.19 (gGAE/l) * 18.89 (gGAE/g sample)/ 170.1 
(g/mol)) which is 21 µM GAE. Interestingly, the 
IC50 for pure gallic acid for MDA-
was 47 µM with 24 hr treatment [32].
 
 
Fig. 2. Zones of inhibition for disc diffusion assay of 
Gram +ve (B. cereus, S. aureus S. epidermis
Pseudomonas aeruginosa 17
Extract 1 mg/ml (1 mg/ disk), 3 control antibiotics and PBS as an additional control. 
deviation. 6 mm is size of antibiotic disk. Number of replicates n=2
Barnes et al.; JABB, 5(1): 1-6, 2016; Article no.JABB.
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-MB-
here is 
         
 in terms of 
MB-231 cells 
 
3.3 Antibacterial Activities 
  
Previous investigations found, that 
extracts show antimicrobial activity towards both 
Gram negative and Gram positive strains but, 
that the degree of effectiveness varied with plant 
components (leaf > root extracts), extraction 
solvent (methanol, chloroform > water > 
petroleum ether) and dose of bioactive agent 
applied [7,15-19]. The present study (
show that W. somnifera aqueous-root extract had 
no antimicrobial effects at the dose tested 
(1mg/ml; 1mg addition/disc). Of particular note, 
previous investigations using disc diffusion 
testing required a concentration range of 20
mg/ml of extract with 4-5 mg solid per disc or well
[16,17]. A methanolic W. somnifera
(5mg/ml and 200 µl or 1 mg addition per disc) 
showed antimicrobial activity but lower 
concentrations were not tested [8]. Aqueous and 
chloroform extracts of W. somnifera
(10 mg/ml; 100 µl or 1 mg addition per disc) 
showed antimicrobial results [33]. 
investigations using 100 mg/ml extract (10
addition/ disc) found aqueous, ethanol and 
acetone extracts of W. somnifera
similar antimicrobial activity [17,34].
Withania somnifera extract using 
) and Gram -ve (Salmonella typhi, E.
) bacteria 
Error bars are standard 
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4. CONCLUSION 
 
Withania somnifera aqueous root extract was 
demonstrated to have potent antioxidant activity.  
Freeze drying the W. somnifera root extract 
further increased the TAC per dry weight basis 
by 5-11 fold and is expected to also preserve 
antioxidant activity. Aqueous-root extracts        
W. somnifera showed anticancer activity 
(IC50~0.19 mg/ml) but no antibacterial ability 
was detectable at such doses. This preliminary 
study is the first to compare, antioxidant, 
anticancer and antimicrobial activity of W. 
somnifera extracts. The results, supported by 
emerging literature, suggest that the effective 
dose for W. somnifera anticancer activity is 1-
order of magnitude lower compared to 
concentrations for antimicrobial activity according 
to the strain of bacterial tested in this study.  
Further research is required to improve current 
understanding of the anticancer and antimicrobial 
properties Withania. 
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